跳至主要内容
临床试验/ACTRN12624000709549
ACTRN12624000709549进行中(未招募)Unknown

Incidence of periprocedural bacteraemia associated with transcatheter aortic valve implantation (TAVI)

Dr Christopher Robson0 个研究点目标入组 75 人开始时间: 2024年6月6日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • undergoing a clinically indicated TAVI procedure via a transfemoral approach OR undergoing coronary angiography via a transfemoral approach (comparator group)
  • able to provide informed consent

排除标准

  • known bacteraemia within 30 days prior to TAVI procedure
  • receipt of systemic antibiotic therapy within 5 days prior to TAVI procedure (other than procedural prophylaxis)

研究者

发起方
Dr Christopher Robson

相似试验